Ex-Radius Health Exec Carmona Joins Rubius as Chief Financial Officer

Rubius Therapeutics (NASDAQ: [[ticker:RUBY]]) has appointed Jose “Pepe” Carmona to serve as its chief financial officer, the same position he held most recently at Radius Health (NASDAQ: [[ticker:RDUS]]). Cambridge, MA-based Rubius is engineering red blood cells into potential therapies. Earlier this year, Rubius stopped work on its lead drug candidate for a rare metabolic disorder and shifted its priorities to developing treatments for cancer and autoimmune diseases. The company’s new lead therapeutic candidate, RTX-240, is in early-stage testing for solid tumors.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.